Literature DB >> 23009910

Chronic thromboembolic pulmonary hypertension: a review of current practice.

Jennifer Haythe1.   

Abstract

Pulmonary artery hypertension is a complex and multi-faceted disease process with numerous etiologies. Chronic thromboembolic pulmonary hypertension (CTEPH) is an underdiagnosed and highly treatable form of pulmonary hypertension. In this disease, certain patients with a history of pulmonary thromboembolic disease go on to develop elevated pulmonary artery pressures, shortness of breath, and progressive right heart failure. This article will review the epidemiology, pathophysiology, diagnosis and treatment of CTEPH with a review of pulmonary thromboendarterectomy surgery.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23009910     DOI: 10.1016/j.pcad.2012.07.005

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  10 in total

1.  Prevalence of coronary artery-pulmonary artery collaterals in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Noel S Lee; Daniel G Blanchard; Kirk U Knowlton; Anna M McDivit; Victor Pretorius; Michael M Madani; Peter F Fedullo; Kim M Kerr; Nick H Kim; David S Poch; William R Auger; Lori B Daniels
Journal:  Pulm Circ       Date:  2015-06       Impact factor: 3.017

2.  Severity of arterial and chronic thromboembolic pulmonary hypertension is associated with impairment of heart rate turbulence.

Authors:  Piotr Bienias; Maciej Kostrubiec; Zuzanna Rymarczyk; Dariusz Korczak; Michał Ciurzyński; Marcin Kurzyna; Adam Torbicki; Anna Fijałkowska; Piotr Pruszczyk
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-05       Impact factor: 1.468

3.  Hypoxia-inducible factor 1 alpha contributes to pulmonary vascular dysfunction in lung ischemia-reperfusion injury.

Authors:  Xin Zhao; Yanwu Jin; Haibo Li; Zhigang Wang; Wanlin Zhang; Chang Feng
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

4.  Pulmonary arteriovenous malformation in chronic thromboembolic pulmonary hypertension.

Authors:  Arun Sharma; Gurpreet S Gulati; Neeraj Parakh; Abhinav Aggarwal
Journal:  Indian J Radiol Imaging       Date:  2016 Apr-Jun

5.  PEAR1 gene polymorphism in a Chinese pedigree with pulmonary thromboembolism.

Authors:  Yingyun Fu; Silong Sun; Jie Liang; Shengguo Liu; Yiqi Jiang; Lan Xu; Junpu Mei
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

6.  The Development of Marked Collateral Circulation due to Inferior Vena Cava Filter Occlusion in a Patient with Chronic Thromboembolic Pulmonary Hypertension Complicated with Anti-phospholipid Syndrome.

Authors:  Hajime Kasai; Nobuhiro Tanabe; Ken Koshikawa; Yasutaka Hirasawa; Toshihiko Sugiura; Seiichiro Sakao; Koichiro Tatsumi
Journal:  Intern Med       Date:  2017-04-15       Impact factor: 1.271

7.  Study of Cardiac Arrest Caused by Acute Pulmonary Thromboembolism and Thrombolytic Resuscitation in a Porcine Model.

Authors:  Lian-Xing Zhao; Chun-Sheng Li; Jun Yang; Nan Tong; Hong-Li Xiao; Le An
Journal:  Chin Med J (Engl)       Date:  2016-07-05       Impact factor: 2.628

8.  High Frequency of Pulmonary Hypertension-Causing Gene Mutation in Chinese Patients with Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Qunying Xi; Zhihong Liu; Zhihui Zhao; Qin Luo; Zhiwei Huang
Journal:  PLoS One       Date:  2016-01-28       Impact factor: 3.240

Review 9.  Chronic Thromboembolic Pulmonary Hypertension - What Have We Learned From Large Animal Models.

Authors:  Kelly Stam; Sebastian Clauss; Yannick J H J Taverne; Daphne Merkus
Journal:  Front Cardiovasc Med       Date:  2021-04-16

10.  Elimination of fibrin γ-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi.

Authors:  Cédric Duval; Adomas Baranauskas; Tímea Feller; Majid Ali; Lih T Cheah; Nadira Y Yuldasheva; Stephen R Baker; Helen R McPherson; Zaher Raslan; Marc A Bailey; Richard M Cubbon; Simon D Connell; Ramzi A Ajjan; Helen Philippou; Khalid M Naseem; Victoria C Ridger; Robert A S Ariëns
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-06       Impact factor: 11.205

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.